Longitudinal Study of HTLV‐III‐Infected Chimpanzees by Lymphocyte Subpopulation Analysis

Abstract
Following inoculation with plasma from human patients with AIDS, two chimpanzees demonstrated specific antihuman T‐cell leukemia virus type 3 (HTLV‐III) antibodies. One of the two chimpanzees also developed massive lymphadenopathy that persisted for 32 weeks and demonstrated a concurrent and more frequent depression of total T cells (T3) and T helper cells (T4) with a decrease in the ratios of T4 to T suppressor cells (T8). These results indicate that chimpanzees demonstrate a range of T‐cell subpopulations during infection and disease induced by HTLV‐III.
Funding Information
  • U.S. Public Health Service
  • National Heart, Lung, and Blood Institute (NO1‐HB‐2‐7004, NO1‐CL‐1‐2115, HL‐32505)